Jump to content

Drilldown: Medicines

Choose a table:


Medicines > classes : Anti-CGRP ligand monoclonal antibody or Neuroleptic & duration: 3-month dosing interval

Use the filters below to narrow your results.

generic:
None (1)
brand:
Vyepti (1)
classes: (Click arrow to add another value)
mechanism:
Humanized IgG1 monoclonal antibody binding CGRP peptide; IV infusion enables fastest onset of any CGRP mAb (1)
uses:
Preventive treatment of migraine in adults (1)
starting dose:
100 mg IV every 3 months; may increase to 300 mg IV every 3 months (1)
preparations:
100 mg/mL vial for IV infusion (1)
fda max:
300 mg/quarter (1)
routes:
Intravenous infusion (1)
onset:
Effect demonstrated within 24 hours in some patients (1)
duration: (Click arrow to add another value)
halflife:
~27 days (1)
bioavailability:
100% (IV) (1)
pregnancy:
Limited data; avoid (1)
legal:
Rx (1)

Showing below up to 1 result in range #1 to #1.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"